| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | CA2263838A1 Crystal structures of a protein tyrosine kinase |
| 02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
| 02/26/1998 | CA2263830A1 T1 receptor-like ligand i |
| 02/26/1998 | CA2263803A1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination |
| 02/26/1998 | CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | CA2263744A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263189A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | CA2263149A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
| 02/26/1998 | CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum |
| 02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | CA2263137A1 Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2262515A1 Hbv polymerase, rnase h enzyme derived from hbv polymerase, processes for preparation and uses for screening antiviral agents thereof |
| 02/26/1998 | CA2259310A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/26/1998 | CA2235148A1 Novel dnas and process for producing proteins by using the same |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/25/1998 | EP0825442A2 Morphogenic protein screening method |
| 02/25/1998 | EP0825265A1 Method for specifically amplifying a cDNA of an extremely small quantity |
| 02/25/1998 | EP0825262A2 Tissue-specific toxin expression in plants |
| 02/25/1998 | EP0825261A2 Purine nucleosidase from Ochrobactrum anthropi |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
| 02/25/1998 | EP0824918A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-$g(k)B |
| 02/25/1998 | EP0824863A2 Baking method and associated apparatus |
| 02/25/1998 | EP0824599A2 Universal targets for species identification |
| 02/25/1998 | EP0824597A1 Assay and method for transcript imaging |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824593A2 Engineering protein posttranslational modification in transgenic organisms |
| 02/25/1998 | EP0824592A1 Alkaline protease and process for its production |
| 02/25/1998 | EP0824591A1 Transgenic carnations exhibit prolonged post-harvest life |
| 02/25/1998 | EP0824590A1 Vasoactive intestinal peptide |
| 02/25/1998 | EP0824589A1 Utrophin gene promoter |
| 02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
| 02/25/1998 | EP0824586A1 Human uridine diphosphate galactose-4-epimerase |
| 02/25/1998 | EP0824585A1 Protease variants and compositions |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824542A1 End-complementary polymerase reaction |
| 02/25/1998 | EP0824540A1 Nucleic acid ligands of tissue target |
| 02/25/1998 | EP0824362A1 Biosynthetic virus vectors for gene therapy |
| 02/25/1998 | EP0824361A1 Stable virus packaging cell lines |
| 02/25/1998 | EP0765387A4 Method for increasing transduction of cells by adeno-associated virus vectors |
| 02/25/1998 | EP0711304B1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/25/1998 | CN1174574A DNA which regulates gene expression in coryne-form bacteria |
| 02/25/1998 | CN1174573A Human vascular IBP-like growth factor |
| 02/25/1998 | CN1174572A Human tissue inhibitor of metalloproteinase -4 |
| 02/25/1998 | CN1174559A Major outer membrane protein CD of Moraxella |
| 02/25/1998 | CN1174558A Tumor necrosis factor-Gamma |
| 02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
| 02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
| 02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
| 02/25/1998 | CN1174238A Biomycin producing method utilizing gene engineering technology |
| 02/25/1998 | CN1174236A Production of gamma linolenic acid by delta6 -desaturase |
| 02/25/1998 | CN1174235A Genetic transformation and regeneration method for capsicum plant |
| 02/24/1998 | US5721367 Homologous recombination in mammalian cells |
| 02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
| 02/24/1998 | US5721353 DNAs coding for LCU13 ! motilin |
| 02/24/1998 | US5721352 Entomopoxvirus expression system |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721349 Genetically altered mutant strain |
| 02/24/1998 | US5721348 DNA encoding PH-20 proteins |
| 02/24/1998 | US5721341 Derivatives of nucleosides, processes for the production of these derivatives of nucleosides and specific polyclonal and monoclonal antibodies of these derivatives |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721138 Apolipoprotein(A) promoter and regulatory sequence constructs and methods of use |
| 02/24/1998 | US5721137 Stable synthetic promoter which controlls expression of a heterologous gene in escherichia and bacillus |
| 02/24/1998 | US5721133 Hybrid regulatory proteins which contain amino acid sequences that are susceptible to cleavage by specific proteolytic enzymes; alters rate of production of products of indicator genes |
| 02/24/1998 | US5721132 Synthetic gene for D4 dopamine receptors |
| 02/24/1998 | US5721130 Monitoring alzheimer's disease |
| 02/24/1998 | US5721128 Process for the production of novel pullulanase |
| 02/24/1998 | US5721127 Isolated from bacillus deramificans |
| 02/24/1998 | US5721126 Method for cloning and producing the SCaI restriction endonuclease in E. coli |
| 02/24/1998 | US5721119 Nucleic acid sequences |
| 02/24/1998 | US5721118 Selecting a centromeric fragment which contains less dna than is present in a normal haploid cell |
| 02/24/1998 | US5721114 Cultivating a transformed escherichia strain in culture medium, inducing expression of apolipoprotein a1-m protein of specific amino acid sequence in logarithmic growth phase before stationary phase is attained, separating the product |
| 02/24/1998 | US5721113 Polynucleotide encoding new ets-related factor 1 |
| 02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5721104 Screening assay for anti-HIV drugs |
| 02/24/1998 | US5720959 Malaria vaccine |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720952 Administering colony stimulating factor |
| 02/24/1998 | US5720936 Screening compounds for effect on alzheimer*s disease by administering to transgenic mouse bearing nucleic acid construct coding for amyloid precursor protein, determining altered expression or processing of said protein |
| 02/24/1998 | US5720923 Automatic; polymerase chain rection by thermal cycling |
| 02/24/1998 | CA1339684C Plant ubquitin promoter system |
| 02/24/1998 | CA1339683C Haloarylnitrile degrading gene, its use, and cells containing the gene |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/23/1998 | CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 02/19/1998 | WO1998007036A1 Process for determining the status of an organism by peptide measurement |
| 02/19/1998 | WO1998007033A1 Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 02/19/1998 | WO1998007030A1 In vitro assay for carcinogens using phenotypic transformation of human cells |
| 02/19/1998 | WO1998006877A2 Method for removing amplification inhibitors from test samples |
| 02/19/1998 | WO1998006869A1 Non-viral vehicles for use in gene transfer |
| 02/19/1998 | WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | WO1998006863A1 A vector for polynucleotide vaccines |